ZURA zurabio.com Total Asset Value of Company
Zura Bio Limited (ZURA) focuses on developing antibodies for autoimmune disorders, which creates high risks due to the absence of commercial sales. Business success relies on test results and securing investments, and this price chart reflects total assets at 169.27. Meanwhile, the company minimizes costs by outsourcing production and research to external partners.
Analytical breakdowns and data insights for company Zura Bio Limited (ZURA)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Zura Bio Limited|ZURA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio zurabio.com|ZURA - Company Aggregate Debts|Debts to Book Capitalization Zura Bio|ZURA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Zura Bio|Interim Coverage Ratio zurabio.com
- net income and valuation multiples indicators:
Fundamental valuation:Zura Bio Limited
Investors are verifying the financial stability of the issuer by comparing resource management efficiency with market capitalization. By analyzing consolidated asset trends, reverse-engineered via ROA, one can assess the total value of Zura Bio Limited (ZURA) assets and liabilities. For a biotech startup, this metric reflects the ability to sustain costly clinical trials. However, the high burn rate of R&D capital creates a risk of share dilution as the current resource base is depleted.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA: Cumulative Company Assets|Total Asset Value of Company RIGL|ANAB (AnaptysBio, Inc.) - Cumulative Company Assets|astriatx.com (ATXS) - Company Total Assets|Aggregate Company Assets enGene|RAPT: Aggregate Asset Value|Company Total Assets JBIO|Company Total Assets Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics - Cumulative Company Assets|Aggregate Asset Value TLSA|Cabaletta Bio - Company Total Assets|VTYX: Aggregate Company Assets|THTX: Company Total Assets|AVTX - Company Total Asset Base|Aggregate Company Assets Eledon Pharmaceuticals|Company Assets agenusbio.com AGEN|Cumulative Company Assets CLYM (Climb Bio)|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Aggregate Company Assets Adagene Inc. ADAG|ImageneBio - Aggregate Company Assets|Shattuck Therapeutics - Company Total Assets|Company Total Asset Base Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Aggregate Company Assets|Cumulative Company Assets Immunic|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|InflaRx GmbH (IFRX) - Company Total Asset Base|Cumulative Company Assets XFOR (X4 Pharmaceuticals)|Aggregate Business Assets ACET|Company Total Assets CELU (Celularity)|INmune Bio Inc (INMB) - Company Assets|Barinthus Bio - Company Total Assets|KZR (Kezar Life Sciences Inc) - Total Business Assets|SABS (SAB Biotherapeutics) - Cumulative Company Assets|Total Asset Value of Company AKTX (akaritx.com)|Cumulative Company Assets ENLV|Company Total Assets Q32 Bio Corp|Aggregate Company Assets GeoVax Labs Inc (GOVX)|EDSA (Edesa Biotech Corp) - Aggregate Asset Value|Company Total Assets IBIO (iBio, Inc.)|Company Total Assets Carisma Therapeutics Inc CARM|XTLB - Aggregate Company Assets|Total Asset Value of Company BOLT|HCWB: Company Total Assets|Aptevo Therapeutics Inc. - Aggregate Asset Value|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Company Total Assets Aditxt Corp|Aggregate Company Assets GRI Bio (GRI)|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Aggregate Company Assets ReShape Lifesciences HIND|REVB - Cumulative Company Assets|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|CALI (calcimedica.com) - Cumulative Company Assets|Affimed N.V. - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|HOOKIPA (HOOK) - Company Total Asset Base|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|Cumulative Company Assets iteostherapeutics.com ITOS|Aggregate Company Assets Ocean Biomedical OCEA|TCBP - Cumulative Company Assets|THRD: Cumulative Company Assets